biote Corp
NASDAQ: BTMD · HEALTHCARE · MEDICAL CARE FACILITIES
Updated 2026-06-05
biote Corp (BTMD) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $109.98M | $21.29M | 60.39% | 21.39% | 19.36% |
| 2020 | $116.57M | $29.16M | 61.46% | 27.26% | 25.02% |
| 2021 | $139.40M | $32.62M | 64.98% | 24.79% | 23.40% |
| 2022 | $164.96M | $-969000.00 | 66.92% | -36.81% | -0.59% |
| 2023 | $185.36M | $3.32M | 68.78% | 15.46% | 1.79% |
| 2024 | $197.19M | $3.16M | 70.52% | 16.03% | 1.60% |
| 2025 | $192.22M | $27.05M | 69.76% | 20.35% | 14.07% |
Frequently asked questions
What is biote Corp's revenue?
biote Corp's trailing twelve-month revenue is $188.16M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is BTMD?
In its most recent fiscal year, BTMD ran a gross margin of 69.76%, an operating margin of 20.35%, and a net margin of 14.07%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does BTMD generate?
BTMD produced $30.18M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is BTMD's balance sheet healthy?
BTMD holds $24.12M in cash and equivalents against $100.78M in long-term debt, on $-58.54M of shareholder equity. That debt is best read against the cash flow the business throws off each year.